News|Articles|September 8, 2023
Distinguish Protein from Non-Protein Particles in Biologic Formulations
Author(s)Halo Labs
This application note demonstrates how Aura® systems can quickly and accurately characterize therapeutics for particles and product purity and stability.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
E&L Challenges in Biologics, Part One
2
UK Report Says Persistent Failure to Commercialize R&D Threatens Life Sciences
3
E&L Challenges in Biologics, Part Two
4
Why Biopharma Developers Should Care About FDA’s New Personalized Therapy Approval Process
5
